USSTOCK.TODAY
Market Closed
Log in Sign up

Protalix BioTherapeutics Exceeds Q3 Earnings and Revenue Estimates

Earnings Whispers · ·by G4L

PLX
PLX Protalix BioTherapeutics Inc
$2.96 -5.43%
View chart & analysis →
  1. 1Protalix BioTherapeutics Inc reported Q3 earnings per share of $0.05, beating the consensus estimate of a $0.02 loss.
  2. 2Protalix BioTherapeutics Inc achieved Q3 revenue of $21.93 million, surpassing expectations.
  3. 3Management reaffirmed its 2026 total revenue guidance of $78 million to $83 million and expects to meet or exceed it.

So what's the key point?

Protalix BioTherapeutics Inc earned more money than expected. Both earnings and revenue came in higher than what experts had predicted.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Protalix BioTherapeutics Inc. Reports $4 million in Third Quarter Profit Associated Press · 2d agoPalladyne AI Corp records record revenue but misses EPS and sees slowing orders Earnings Whispers · yesterdayExagen misses consensus with loss per share Earnings Whispers · yesterday
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news